Literature DB >> 22592210

Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.

Jung-Jyh Hung1, Wen-Juei Jeng, Wen-Hu Hsu, Teh-Ying Chou, Biing-Shiun Huang, Yu-Chung Wu.   

Abstract

OBJECTIVE: This study investigated the factors predicting recurrence and death in patients with resected stage-I non-small-cell lung cancers according to the 7th edition of tumor, node, metastasis (TNM) classification for lung cancer.
METHODS: All patients undergoing surgical resection for pathological stage-I non-small-cell lung cancers at Taipei Veterans General Hospital between 1980 and 2000 were retrospectively reviewed. Those undergoing sublobar resection were excluded. The factors predicting overall survival (OS), overall recurrence, local recurrence, and distant metastasis were investigated.
RESULTS: A total of 756 patients were eligible. The 5-year OS rate and probability of freedom from recurrence were 57.3% and 70.2%, respectively. The 2-year local-recurrence-free and distant-metastasis-free rates were 90.7% and 82.1%, respectively. In multivariable analysis, the new T descriptor (T1a, T1b, and T2a) was the common factor that significantly affected OS (p = 0.003), overall recurrence (p = 0.004), and distant metastasis (p < 0.001). Smoking index more than 20, and number of mediastinal lymph nodes dissected/sampled of 15 or fewer were common factors that significantly predicted worse OS (p < 0.001, p < 0.001, respectively), lower probability of freedom from overall recurrence (p = 0.025, p = 0.009, respectively), and higher risk of local recurrence (p < 0.001, p = 0.030, respectively). Non-squamous-cell histology predicted higher risk of distant metastasis (p = 0.006).
CONCLUSIONS: Risks of death and recurrence increase as the T descriptor upgrades in the new TNM system. The combination of risk factors can be used to identify high-risk subgroups of local recurrence and distant metastasis.

Entities:  

Mesh:

Year:  2012        PMID: 22592210     DOI: 10.1097/JTO.0b013e31824cbad8

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  31 in total

1.  Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence.

Authors:  Chanyeong Park; In Jae Lee; Seung Hun Jang; Jae Woong Lee
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  Prognostic Impact of Tumor Spread Through Air Spaces in Non-small Cell Lung Cancers: a Meta-Analysis Including 3564 Patients.

Authors:  Huining Liu; Qifan Yin; Guang Yang; Peng Qie
Journal:  Pathol Oncol Res       Date:  2019-02-14       Impact factor: 3.201

3.  Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.

Authors:  Youngkyu Moon; Kyo Young Lee; Jae Kil Park
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

4.  Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.

Authors:  Joshua A Roth; Paul Billings; Scott D Ramsey; Robert Dumanois; Josh J Carlson
Journal:  Oncologist       Date:  2014-04-07

5.  Poor survival for veterans with pathologic stage I non-small-cell lung cancer.

Authors:  Jamii B St Julien; Rhonda Pinkerman; Melinda C Aldrich; Heidi Chen; Stephen A Deppen; Carol Callaway-Lane; Pierre Massion; Joe B Putnam; Eric S Lambright; Jonathan C Nesbitt; Eric L Grogan
Journal:  Am J Surg       Date:  2012-08-18       Impact factor: 2.565

6.  It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival.

Authors:  Michael C Roach; Sana Rehman; Todd A DeWees; Christopher D Abraham; Jeffrey D Bradley; Cliff G Robinson
Journal:  Pract Radiat Oncol       Date:  2015-09-18

7.  Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.

Authors:  Yongkai Wu; Bo Huang; Qian Liu; Yongyu Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

8.  Circular RNA ABCB10 promotes non-small cell lung cancer progression by increasing E2F5 expression through sponging miR-584-5p.

Authors:  Dongjie Ma; Yingzhi Qin; Cheng Huang; Yeye Chen; Zhijun Han; Xiaoyun Zhou; Hongsheng Liu
Journal:  Cell Cycle       Date:  2020-05-18       Impact factor: 4.534

9.  Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".

Authors:  Chigozirim N Ekeke; Chandler Mitchell; Matthew Schuchert; Rajeev Dhupar; James D Luketich; Olugbenga T Okusanya
Journal:  Clin Lung Cancer       Date:  2020-09-18       Impact factor: 4.785

10.  Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors.

Authors:  Yiyang Wang; Difan Zheng; Jizhuang Luo; Jie Zhang; Cecilia Pompili; Hideki Ujiie; Natsumi Matsuura; Haiquan Chen; Feng Yao
Journal:  Transl Lung Cancer Res       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.